Variation in plasminogen-activator-inhibitor-1 gene and risk of meningococcal septic shock
- 1 August 1999
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 354 (9178) , 561-563
- https://doi.org/10.1016/s0140-6736(98)09376-3
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The Relationship between Plasminogen Activator Inhibitor-1 and Proinflammatory and Counterinflammatory Mediators in Children with Meningococcal Septic ShockThe Journal of Infectious Diseases, 1996
- Release of Tumor Necrosis Factor: An Innate Host Characteristic that May Contribute to the Outcome of Meningococcal DiseaseThe Journal of Infectious Diseases, 1995
- Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction.Proceedings of the National Academy of Sciences, 1995
- Leukaplasmapheresis in meningococcal septic shockThe American Journal of Medicine, 1992
- Severity of childhood bacterial meningitis and duration of illness before diagnosisThe Lancet, 1991
- Types 1 and 2 Plasminogen Activator lnhibitor and Tirmor Necrosis Factor Alpha in Fatients with SepsisThrombosis and Haemostasis, 1990
- Plasminogen activator inhibitor 1 and 2, alpha-2-antiplasmin, plasminogen, and endotoxin levels in systemic meningococcal diseaseThrombosis Research, 1990
- Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro.Journal of Clinical Investigation, 1987
- Endotoxin Liberation from Neisseria meningitidis Isolated from Carriers and Clinical CasesScandinavian Journal of Infectious Diseases, 1987
- Adrenal, cutaneous and myocardial lesions in fulminating endotoxinemia: (Waterhouse-Friderichsen Syndrome)Pathology - Research and Practice, 1982